A Health Affairs study published Nov. 3 examined an increase in states banning prior authorizations in private insurance plans for opioid use disorder medications.
(The Center Square) – President Donald Trump and his administration plan to inform Congress about using the military to target drug traffickers, but stopped short of saying they would ask for ...
The president said he would bypass Congress rather than ask for approval for his military campaign against drug traffickers, even as he said it would expand from sea to land. By Robert Jimison Robert ...
The Idaho Medical Freedom Act makes it illegal to require anyone to take a vaccine or receive “medical intervention.” Leslie Manookian, the activist behind the law, hopes to make it a “societal norm” ...
Surescripts®, the nation's leading health intelligence network, today announced a major expansion of its Touchless Prior Authorization technology, now reaching more than 76,000 prescribers across the ...
CHICAGO, October 08, 2025--(BUSINESS WIRE)--Emalex Biosciences today announced that the U.S. Food and Drug Administration has authorized the company’s Expanded Access Program (EAP) for ecopipam, an ...
Good morning, and thank you for standing by. [Operator Instructions] Please be advised that today's conference call is being recorded. I would now like to turn the conference over to Michael Polyviou.
The GenAI-powered platform automates benefit verification, prior authorization, and payer follow-up to reduce treatment delays and manual burden Develop Health, an EHR-integrated benefits‑verification ...
Form 14A Application from a purchaser for test or analysis of a drug under Section 26 of the Drugs and Cosmetics Act, 1940 Download Now Form 19 Application for grant or renewal of a licence to sell, ...
Eli Lilly (the company behind Mounjaro and Zepbound) just announced impressive phase 3 clinical trial results for a new weight loss medication, orforglipron, a GLP-1. Orforglipron is an oral ...
This is the third part of an investigative series, Medicated in Foster Care: Who’s Looking Out? by The Imprint, a national nonprofit news outlet covering child welfare and youth justice. Sign up for ...
Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines. The de novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback